Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022 at 10:30am (EST).

Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005958/en/

DexCom, Inc.
Sean Christensen
Senior Director – Investor Relations and Corporate FP&A
[email protected]
(858) 200-0200

Source: DexCom, Inc.

You May Also Be Interested In

• Deutsche Bank Starts DexCom (DXCM) at Buy
• Next Crypto to Explode in 2026: Why Pepeto’s Presale Is Outpacing the Competition
• Best Crypto to Invest in as Ethereum Cuts 54 Jobs While Pepeto Quietly Passes $10.3 Million